Los Angeles

Epidemiological Brief

Los Angeles scores 24.67 (LOW risk) as of 2026-08-07. Influenza-like illness is the dominant signal, contributing 36.4/100 based on an ILI rate of 10.1% — elevated relative to the regional summer baseline for California. Dengue and mpox each contribute 20/100 at sentinel-level; dengue reflects travel-associated cases in the greater LA region, and mpox represents ongoing low-level community transmission in Southern California. Pertussis contributes 17.7/100, indicating persistent whooping cough activity in California. Measles scores 8.8/100 with low incidence. COVID-19 is at background levels. Wastewater surveillance (ATCP-73RE) monitors COVID-19 and influenza with no alert triggered. Data coverage is medium (85%), providing moderate confidence. Conditions are warm and dry (24°C, 73% relative humidity, no precipitation). International arrivals total 21,580 — one of the largest volumes among US host cities. Standard precautions apply: respiratory hygiene for influenza and COVID-19, mosquito-bite prevention for dengue, and pertussis vaccination verification for unvaccinated individuals. No immediate enhanced measures are required beyond routine tournament health protocols.

Model SCEME v3.1 · Updated August 7, 2026

Please consult a local doctor or pharmacist for guidance and medication.